Efficacy of individualized homeopathic medicines in irritable bowel syndrome: A double-blind randomized, placebo-controlled trial

Jameson, 2020, 811 Gwee, 2004, The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community, Am J Gastroenterol, 99, 924, 10.1111/j.1572-0241.2004.04161.x Basseri, 2011, Antibiotics for the Treatment of Irritable Bowel Syndrome, Gastroenterol Hepatol, 7, 455 Adeyemo, 2010, Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?, Aliment Pharmacol Ther, 32, 738, 10.1111/j.1365-2036.2010.04409.x Kang, 2005, Systematic review: the influence of geography and ethnicity in irritable bowel syndrome, Aliment Pharmacol Ther, 21, 663, 10.1111/j.1365-2036.2005.02396.x Lovell, 2012, Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis, Clin Gastroenterol Hepatol, 10, 712, 10.1016/j.cgh.2012.02.029 Gwee, 2018, Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management, J Gastroenterol Hepatol, 33, 99, 10.1111/jgh.13987 Gwee, 2005, Irritable bowel syndrome in developing countries – a disorder of civilization or colonization?, Neurogastroenterol Motil, 17, 317, 10.1111/j.1365-2982.2005.00627.x Makharia, 2011, Prevalence of irritable bowel syndrome: a community based study from Northern India, Neurogastroenterol Motil, 17, 82, 10.5056/jnm.2011.17.1.82 Nagaonkar, 2018, A study of prevalence and determinants of irritable bowel syndrome in an urban slum community in Mumbai, J Datta Meghe Inst Med Sci Univ, 13, 87, 10.4103/jdmimsu.jdmimsu_4_18 Rahman, 2017, Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review, World J Gastroenterol, 23, 6788, 10.3748/wjg.v23.i37.6788 Maxion-Bergemann, 2006, Costs of irritable bowel syndrome in the UK and US, Pharmacoeconomics, 24, 21, 10.2165/00019053-200624010-00002 Wu, 2010, Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome: facts or myths?, Gastroenterol Hepatol, 6, 705 Yi-Hao, 2009, Complementary and alternative medicine for treatment of irritable bowel syndrome, Can Fam Physician, 55, 143 Cauffield, 2000, The psychosocial aspects of complementary and alternative medicine, Pharmacotherapy, 20, 1289, 10.1592/phco.20.17.1289.34898 Scaciota, 2021, Interventions for the treatment of irritable bowel syndrome: a review of Cochrane systematic reviews, Arq Gastroenterol, 58, 120, 10.1590/s0004-2803.202100000-20 Peckham, 2019, Homeopathy for treatment of irritable bowel syndrome, Cochrane Database of Systematic Reviews Rahlfs, 1976, Treatment of irritable colon. A multi-center placebo-controlled double-blind study in general practice [Ein multizentrischer plazebo-kontrollierter doppelblindversuch in der allgemeinen praxis], Arzneimittel Forschung, 26, 2230 Rahlfs, 1979, Asa foetida in the treatment of the irritable colon; a double-blind trial [Asa foetida bei colon irritabile], Deutsche Medizinische Wochenschri, 104, 140, 10.1055/s-0028-1103859 Lecoyte, 1993, An investigation into the homeopathic treatment of patients with irritable bowel syndrome Peckham, 2014, Interim results of a randomised controlled trial of homeopathic treatment for irritable bowel syndrome, Homeopathy, 103, 172, 10.1016/j.homp.2014.05.001 Uchiyama-Tanaka, 2018, Case study of homeopathic bowel nosode remedies for dysbiotic Japanese patients, J Altern Complement Med, 24, 187, 10.1089/acm.2017.0061 Nahar, 2019, An open-label randomized pragmatic non-inferiority pilot trial to compare the effectiveness of Dysentery compound with individualized homeopathic medicines in irritable bowel syndrome, J Complement Integr Med, 16, 10.1515/jcim-2018-0217 Lacy, 2016, Bowel disorders, Gastroenterology, 150, 1393, 10.1053/j.gastro.2016.02.031 Andrae, 2013, Evaluation of the irritable bowel syndrome quality of life questionnaire (IBS-QOL) in diarrhoea predominant irritable bowel syndrome patients, Health Qual Life Outcomes, 11, 208, 10.1186/1477-7525-11-208 Patrick, 1998, Quality of life in persons with irritable bowel syndrome development and validation of a new measure, Dig Dis Sci, 43, 400, 10.1023/A:1018831127942 Drossman, 2000, Further validation of the IBS-QOL: a disease specific quality of life questionnaire, Am J Gastroenterol, 95, 999, 10.1111/j.1572-0241.2000.01941.x Drossman, 2007, Characterization of health-related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment, Am J Gastroenterol, 102, 1442, 10.1111/j.1572-0241.2007.01283.x Giri, 2021, Psychometric evaluation of the Bengali version of irritable bowel syndrome quality of life questionnaire: A cross-sectional study, J Clin Sci, 18, 42, 10.4103/jcls.jcls_44_20 Francis, 1997, The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress, Aliment Pharmacol Ther, 11, 395, 10.1046/j.1365-2036.1997.142318000.x 2019 1990, EuroQol – a new facility for the measurement of health-related quality of life, Health Policy, 16, 199, 10.1016/0168-8510(90)90421-9 Herdman, 2011, Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L), Qual Life Res, 20, 1727, 10.1007/s11136-011-9903-x Schulz, 2010, CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials, Brit Med J, 340, c332, 10.1136/bmj.c332 Dean, 2007, Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT, Homeopathy, 96, 42, 10.1016/j.homp.2006.11.006 Allen, 1889 Allen, 1979 Blackwood, 2006 Blackwood, 1909 Phatak, 2000 Vermeulen, 2010 Clarke, 1968